The Health and social responses to drug problems: a European guide 2021 was developed to support practitioners and policymakers in tackling the negative consequences of drug use.
The guide is composed of four sets of miniguides that look...
Problematic substance use can be a significant cause of stress for family members of the person using substances. This review, published in the journal Drug: Education, Prevention and Policy, examines current research in order to explore...
The Alcoholics Anonymous (AA) movement created the term "in recovery" to express the continuing requirement for vigilance in order to sustain sobriety (which includes abstinence from alcohol intake) and avoid a return to dangerous drinking...
This online course provides an overview of how community health workers (CHWs) can support their communities by providing appropriate mental health and psychosocial support during the COVID-19 pandemic.
In this course you will learn how...
Social Determinants & Substance Use: A Perspective Beyond the Policy 'Silo' Pragmatics - This paper (synoptic version, peer reviewed and published in Journal of Global Drug Policy & Practice) is a review of and research into the social...
This qualitative study was commissioned by Alcohol Change UK in Wales to explore how and why alcohol and self-harm are related, and how alcohol, self-harm, and related services, are experienced and understood. Eleven...
Tobacco smoking is the greatest cause of sickness and early death worldwide, with 8 million people dying each year from a smoking-related condition. The use of pharmaceutical or behavioural assistance improves smokers' chances of quitting...
The Canadian Centre on Substance Use and Addiction partnered with Health Canada to produce Substance Use and the Workplace: Supporting Employers and Employees in the Trades.
This collection of resources contains links from more than 30...
Opioid overdose deaths can be prevented through timely administration of naloxone, a potent opioid antagonist drug that rapidly reverses the effects of opioid analgesics by binding to the opioid receptors in the central nervous system.
Bec...
The web resource is divided into five sections: "Substances", "Prevention", "Resources", "Practice" and "Get Help". The Resources section contains videos on HIV prevention among people who use stimulants/NPS. This section also includes...
COVID-19 (SARS-CoV-2) was classified a pandemic on March 11, 2020, with early reports of the disease occurring in the Middle East and North African (MENA) area. On January 2021, the World Health Organization Eastern Mediterranean Regional...
People who inject drugs (PWID) are a key population for the elimination of hepatitis C in Europe, and increasing their access to HCV testing and care is a goal in European and national hepatitis C policies. Despite this, HCV testing remains...
This special issue addresses a rapidly growing area of research with a pressing public health need, the social structure of opioid use.
Specifically, this issue compiles original articles that apply theoretical and empirical frameworks to...
The high dropout rate (75%) in opioid use disorder (OUD) treatment among women and racial/ethnic minorities in the United States necessitates a better knowledge of the factors that contribute to treatment success. While therapy and...
In response to the rising efficacy of the illicit opioid drug supply and often observed delays in access to follow-up therapy, emergency departments (EDs) occasionally utilize a high-dose buprenorphine induction method for the treatment of...
Brief treatment (BT) or regular outpatient alcohol use or substance use disorder (SUD) treatment is a key element of the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model. It can be an effective, short-term, and low...
